Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-10-10

Clinical Trial Update: Study of 2LHERP® in Genital Herpes Infections [Phase 4]

View source ↗

Summary

Phase 4 trial update for 2LHERP® in genital herpes infections; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 2LHERP

Snippet

Sponsor: Labo'Life | Conditions: Herpes Simplex, Genital | Phase 4 | Status: TERMINATED